ArticleCancer research communications2026

Phase I Study of Oncolytic Virus VV1 as Monotherapy or in Combination with Avelumab in Patients with Relapsed Refractory Solid Tumors.

Jaime R Merchan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.